365 - Variations and trends in oxygen saturation targeting and retinopathy management in preterm neonates <29 weeks gestation during last decade: An international survey

Elizabeth M. Hurrion, Mater Mothers’ Hospital, Australia, South Brisbane, Queensland, Australia; Malcolm Battin, Auckland City Hospitial, Auckland, Auckland, New Zealand; Mikael Norman, Karolinska Institutet, Stockholm, Stockholms Lan, Sweden; Mark Adams, University Hospital Zurich, Zurich, Zurich, Switzerland; Alina Kowalczykiewicz-Kuta, Clinical Department of Neonatology, Clinical Center of Gynecology Obstetrics and Neonatology, Institute of Medical Sciences, University of Opole, Opole, Opolskie, Poland; Tetsuya Isayama, National Center for Child Health and Development, Setagaya-ku, Tokyo, Japan; Gil Klinger, Schneider Children's Medical Center of Israel and Tel Aviv University, Ramat Hasharon, HaMerkaz, Israel; Laura San Feliciano, Hospital Universitario de Salamanca, Salamanca, Castilla y Leon, Spain; Valerie Biran, Robert Debre Children's Hospital, Assistance Publique Hôpitaux de Paris,University Paris-Cité, INSERM U1141, France, Paris, Ile-de-France, France; Marco Moroni, Azienda Ospedaliera Universitaria Myer - IRCCS, Sesto Fiorentino, Toscana, Italy; Jamil Pedro de Siqueira. Caldas, State University of Campinas, Campinas, Sao Paulo, Brazil; Dirk Bassler, University Hospital of Zurich, Zurich, Zurich, Switzerland; Satoshi Kusuda, Neonatal Research Network of Japan, Taito, Tokyo, Japan; Maximo Vento, Instituto de Investigación Sanitaria La Fe, VALENCIA, Comunidad Valenciana, Spain; Brian Reichman, Sheba Medical Center, Ramat Gan, HaMerkaz, Israel; Neha Goswami, Mount Sinai Hospital, Toronto, ON, Canada; Brian A. Darlow, University of Otago Christchurch New Zealand, Christchurch, Canterbury, New Zealand; Prakesh S. Shah, Mount Sinai Hospital, Toronto, ON, Canada; Kei Lui, University of New South Wales, Sydney, New South Wales, Australia